[1]李若男,郭昆全.新诊断2型糖尿病患者血清铁蛋白与糖、 脂代谢及胰岛功能的关系[J].国际内分泌代谢杂志,2017,37(05):289-292.
 Li Ruonan,Guo Kunquan..Relationship between serum ferritin levels and glycolipid metabolism, islet function in newly diagnosed type 2 diabetic patients[J].International Journal of Endocrinology and Metabolism,2017,37(05):289-292.
点击复制

新诊断2型糖尿病患者血清铁蛋白与糖、 脂代谢及胰岛功能的关系()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
37
期数:
2017年05期
页码:
289-292
栏目:
论著
出版日期:
2017-09-20

文章信息/Info

Title:
Relationship between serum ferritin levels and glycolipid metabolism, islet function in newly diagnosed type 2 diabetic patients
作者:
李若男郭昆全
441000 襄阳,湖北医药学院附属襄阳市第一人民医院内分泌科
Author(s):
Li Ruonan Guo Kunquan.
Department of Endocrinology, Affiliated Dongfeng Hospital of Hubei University of Medicine, Shiyan 442000, China
关键词:
铁蛋白 2型糖尿病 胰岛素抵抗
Keywords:
Ferritin Type 2 diabetes mellitus Insulin resistance
文献标志码:
A
摘要:
目的 比较不同血清铁蛋白(SF)水平的新诊断2型糖尿病(T2DM)患者糖、脂代谢及胰岛功能,分析其与SF的关系。方法 以新诊断T2DM患者115例为观察对象,按SF浓度分为高SF组40例(SF≥274.66 μg/L)与正常SF组75例(21.80 μg/L≤SF<274.66 μg/L)。测量两组患者的身高、体重、腰围、臀围,检测空腹血糖、餐后2 h血糖(2 hPG)、HbA1c、空腹胰岛素(FINS)、总胆固醇、甘油三酯、高密度脂蛋白-胆固醇(HDL-C)、低密度脂蛋白-胆固醇(LDL-C),计算体重指数、腰臀比、稳态模型评估-胰岛素抵抗指数(HOMA-IR)、稳态模型评估-胰岛β细胞功能指数(HOMA-β)、定量胰岛素敏感性指数(QUICKI)和处置指数,并进行Spearman相关性及多元线性回归分析。结果 高SF组体重指数、FINS、甘油三酯、HOMA-IR高于正常SF组(t=2.470、2.631、2.316、2.879,P均<0.05),HDL-C、QUICKI低于正常SF组(t=-2.030、-2.623,P均<0.05); SF水平与体重指数、腰臀比、空腹血糖、2 hPG、HOMA-IR、甘油三酯均呈正相关(r=0.191~0.303,P均<0.05),与HDL-C、QUICKI、处置指数呈负相关(r=-0.221、-0.261、-0.293,P均<0.05); 多元线性回归分析显示体重指数、处置指数和甘油三酯是SF的独立相关因素(β=0.041、-0.443、0.270,P均<0.05)。结论 高SF水平的新诊断T2DM患者其糖、脂代谢紊乱及胰岛素抵抗程度较正常SF的T2DM患者更严重, SF可能通过增加胰岛素抵抗,促进T2DM的发生和发展。
Abstract:
Objective To compare glycolipid metabolism and islet function in patients with newly diagnosed type 2 diabetes mellitus(T2DM)with different levels of serum ferritin(SF)and explore the relationship between glycolipid metabolism, islet function and SF.Methods According to SF concentration, 115 patients with newly diagnosed T2DM were divided into high SF group(SF≥274.66 μg/L, 40 cases)and normal SF group(21.80 μg/L≤SF<274.66 μg/L, 75 cases). Height, weight, waist circumference, hip circumference were measured and fasting plasma glucose(FPG), 2 hours postprandial blood glucose(2 hPG), HbA1c, fasting insulin(FINS), total cholesterol, triglyceride,high density lipoprotein-cholesterol(HDL-C)and low density lipoprotein-cholesterol(LDL-C)were tested, and body mass index, waist-to-hip ratio, homeostasis model assessment insulin resistance index(HOMA-IR), homeostasis model assessment β-cell function index(HOMA-β), quantitative insulin sensitivity index(QUICKI)and disposition index(DI)were calculated. The data were analyzed by Spearman correlation and multivariable linear regression analysis.Results The levels of body mass index, FINS, triglyceride and HOMA-IR in high SF group were significantly higher(t=2.470, 2.631, 2.316, 2.879, all P<0.05), while the levels of HDL-C and QUICK were significantly lower(t=-2.030, -2.623, all P<0.05)compared with those in normal SF group. The level of SF was positively correlated with body mass index, waist-to-hip ratio, FPG, 2 hPG, HOMA-IR and triglyceride(r=0.191-0.303, all P<0.05), but negatively correlated with HDL-C, QUICKI and DI(r=-0.221, -0.261, -0.293, all P<0.05). Multivariate linear regression analysis showed that body mass index, DI and triglyceride were independent related factors of SF(β=0.041, -0.443, 0.270, all P<0.05).Conclusions The newly diagnosed T2DM patients with high level of SF are more severe in glycolipid metabolism and insulin resistance than those with normal SF. SF may promote the occurrence and development of T2DM by increasing insulin resistance.

参考文献/References:

[1] Sun L, Zong G, Pan A, et al. Elevated plasma ferritin is associated with increased incidence of type 2 diabetes in middle-aged and elderly Chinese adults[J].J Nutr,2013,143(9):1459-1465. DOI:10.3945/jn.113.177808.
[2] Fernández-Real JM, Penarroja G, Castro A, et al. Blood letting in high-ferritin type 2 diabetes: effects on insulin sensitivity and beta-cell function[J].Diabetes,2002,51(4):1000-1004.
[3] 张敏,朱彤莹,李芸,等. 非糖尿病腹膜透析患者胰岛素抵抗及脂代谢紊乱相关分析[J]. 复旦学报(医学版),2008,35(3):396-400.DOI:10.3969/j.issn.1672-8467.2008.03.017.
[4] 韩立坤, 卢丹. 血清铁蛋白与2型糖尿病关系的研究[J]. 中国实验诊断学, 2007,11(10):1359-1361. DOI:10.3969/j.issn.1007-4287.2007.10.029.
[5] Williams MJ, Poulton R, Williams S. Relationship of serum ferritin with cardiovascular risk factors and inflammation in young men and women[J].Atherosclerosis,2002,165(1):179-184.
[6] Zhan Y, Tang Z, Yu J. Serum ferritin, diabetes, diabetes control, and insulin resistance[J].Acta Diabetol,2014,51(6):991-998. DOI:10.1007/s00592-014-0656-1.
[7] Yu FJ, Huang MC, Chang WT,et al. Increased ferritin concentrations correlate with insulin resistance in female type 2 diabetic patients[J].Ann Nutr Metab,2012,61(1):32-40. DOI:10.1159/000339265.
[8] Hamed AI, Yousry WA. Correlation between serum ferritin and insulin resistance in hepatitis C-infected Egyptian patients[J]. Egyptian Liver J, 2012,2(2):31-36.
[9] Fernández-Real JM, López-Bermejo A, Ricart W. Iron stores, blood donation, and insulin sensitivity and secretion[J].Clin Chem,2005,51(7):1201-1205. DOI:10.1373/clinchem.2004.046847.
[10] Juanola-Falgarona M, Cándido-Fernández J, Salas-Salvadó J,et al. Association between serum ferritin and osteocalcin as a potential mechanism explaining the iron-induced insulin resistance[J].PLoS One,2013,8(10):e76433. DOI:10.1371/journal.pone.0076433.
[11] Alam F, Fatima F, Orakzai S,et al. Elevated levels of ferritin and hs-CRP in type 2 diabetes[J].J Pak Med Assoc,2014,64(12):1389-1391.
[12] Han LL, Wang YX, Li J,et al. Gender differences in associations of serum ferritin and diabetes, metabolic syndrome, and obesity in the China Health and Nutrition Survey[J].Mol Nutr Food Res,2014,58(11):2189-2195. DOI:10.1002/mnfr.201400088.

相似文献/References:

[1]赵紫琴,雒瑢,田凤石,等.替米沙坦对OLETF大鼠皮下和内脏脂肪组织PPARγ表达的影响[J].国际内分泌代谢杂志,2014,(06):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
 Zhao Ziqin*,Luo Rong,Tian Fengshi,et al.Effects of telmisartan on expression of PPARγ in subcutaneous and visceral adipose tissue in OLETF rats[J].International Journal of Endocrinology and Metabolism,2014,(05):365.[doi:10.3760/cma.j.issn.1673-4157.2014.06.002]
[2]姚霜霜,张翼飞,张志国,等.小檗碱改善代谢性疾病的肠道相关机制[J].国际内分泌代谢杂志,2014,(06):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
 Yao Shuangshuang,Zhang Yifei,Zhang Zhiguo,et al.The gut-related mechanisms of berberine in the treatment of metabolic diseases[J].International Journal of Endocrinology and Metabolism,2014,(05):386.[doi:10.3760/cma.j.issn.1673-4157.2014.06.007]
[3]曹萌 韦晓 刘超.自噬与胰岛β细胞功能及2型糖尿病[J].国际内分泌代谢杂志,2015,(01):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
 Cao Meng,Wei Xiao,Liu Chao..Relationship between autophagy and islet β cells function, type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2015,(05):53.[doi:10.3760/cma.j.issn.1673-4157.2015.01.013]
[4]刘艳 田秀标 韩颖.GLP-1受体激动剂呈葡萄糖依赖性刺激胰岛β细胞胰岛素分泌的机制[J].国际内分泌代谢杂志,2015,(01):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
 Liu Yan*,Tian Xiubiao,Han Ying..Mechanism of GLP-1 receptor agonists in the stimulation of insulin secretion of islet β cell in a glucose-dependent manner[J].International Journal of Endocrinology and Metabolism,2015,(05):66.[doi:10.3760/cma.j.issn.1673-4157.2015.01.017]
[5]齐利琴,刘礼斌.GLP-1在2型糖尿病诱发的阿尔茨海默病治疗中的作用[J].国际内分泌代谢杂志,2016,36(01):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
 Qi Liqin,Liu Libin..Effects of GLP-1 in the treatment of Alzheimer's disease induced by type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(05):48.[doi:10.3760/cma.j.issn.1673-4157.2016.01.012]
[6]梅稳,向光大,卢俊颜,等.GDF11对ApoE-/-糖尿病小鼠内皮依赖性 血管舒张功能的作用[J].国际内分泌代谢杂志,2016,36(02):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
 Mei Wen*,Xiang Guangda,Lu Junyan,et al.Effects of GDF11 on endothelium-dependent vasodiation function of aorta in ApoE-/- diabetic mice[J].International Journal of Endocrinology and Metabolism,2016,36(05):101.[doi:10.3760/cma.j.issn.1673-4157.2016.02.007]
[7]殷俏,张云良,郭淑芹,等.视黄醇结合蛋白4、超敏C反应蛋白 与糖尿病视网膜病变的关系[J].国际内分泌代谢杂志,2016,36(03):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
 Yin Qiao,Zhang Yunliang,Guo Shuqin,et al.Relationship of retinol binding protein 4 and high sensitive C-reactive protein with diabetic retinopathy[J].International Journal of Endocrinology and Metabolism,2016,36(05):149.[doi:10.3760/cma.j.issn.1673-4157.2016.03.02]
[8]王涛,张洁,祁范范,等.不同糖耐量人群血清25(OH)D3水平 及与胰岛β细胞功能的关系[J].国际内分泌代谢杂志,2016,36(04):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
 Wang Tao*,Zhang Jie,Qi Fanfan,et al.Relationship between serum 25(OH)D3 level and islet β cell function in individuals with different glucose tolerance[J].International Journal of Endocrinology and Metabolism,2016,36(05):226.[doi:10.3760/cma.j.issn.1673-4157.2016.04.04]
[9]陈双双,王楚媛,孔令芳.铬与2型糖尿病[J].国际内分泌代谢杂志,2016,36(04):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
 Chen Shuangshuang,Wang Chuyuan,Kong Lingfang.Chromium and type 2 diabetes[J].International Journal of Endocrinology and Metabolism,2016,36(05):272.[doi:10.3760/cma.j.issn.1673-4157.2016.04.13]
[10]涂萍,许婷,段鹏,等.25-羟维生素D3补充对绝经后2型糖尿病 患者胰岛素敏感性及血糖控制的影响[J].国际内分泌代谢杂志,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]
 Tu Ping,Xu Ting,Duan Peng,et al.Influence of 25-hydroxyvitamin D3 supplement on insulin sensitivity and glucose control in postmenopausal patients with type 2 diabetes mellitus[J].International Journal of Endocrinology and Metabolism,2016,36(05):299.[doi:10.3760/cma.j.issn.1673-4157.2016.05.04]

备注/Memo

备注/Memo:
通信作者:郭昆全, Email:oskq@163.com
更新日期/Last Update: 2017-09-30